FNFDCM
BMY icon

Folger Nolan Fleming Douglas Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Folger Nolan Fleming Douglas Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$561K Sell
9,731
-463
-5% -$26.6K 0.05% 115
2026
Q1 		$618K Sell
10,194
-987
-9% -$57.5K 0.06% 109
2025
Q4 		$603K Buy
11,181
+3
+0% +$144 0.06% 101
2025
Q3 		$504K Sell
11,178
-868
-7% -$40.5K 0.05% 111
2025
Q2 		$558K Sell
12,046
-733
-6% -$36K 0.06% 103
2025
Q1 		$779K Sell
12,779
-255
-2% -$14.9K 0.09% 93
2024
Q4 		$737K Buy
13,034
+71
+0.5% +$3.97K 0.08% 97
2024
Q3 		$671K Sell
12,963
-1,009
-7% -$47.3K 0.07% 102
2024
Q2 		$580K Sell
13,972
-2,473
-15% -$111K 0.06% 106
2024
Q1 		$892K Sell
16,445
-455
-3% -$23.2K 0.09% 85
2023
Q4 		$867K Sell
16,900
-46
-0.3% -$2.42K 0.09% 87
2023
Q3 		$984K Sell
16,946
-526
-3% -$32.2K 0.11% 82
2023
Q2 		$1.12M Buy
17,472
+169
+1% +$11.3K 0.12% 84
2023
Q1 		$1.2M Sell
17,303
-1,595
-8% -$112K 0.14% 79
2022
Q4 		$1.36M Buy
18,898
+3,805
+25% +$287K 0.16% 73
2022
Q3 		$1.07M Buy
15,093
+820
+6% +$59.5K 0.15% 78
2022
Q2 		$1.1M Sell
14,273
-775
-5% -$59K 0.14% 79
2022
Q1 		$1.1M Sell
15,048
-5
-0% -$336 0.12% 90
2021
Q4 		$939K Buy
15,053
+1,500
+11% +$88K 0.1% 96
2021
Q3 		$802K Sell
13,553
-400
-3% -$26.3K 0.1% 97
2021
Q2 		$932K Sell
13,953
-350
-2% -$22.8K 0.11% 95
2021
Q1 		$903K Sell
14,303
-461
-3% -$28.7K 0.11% 92
2020
Q4 		$916K Sell
14,764
-75
-0.5% -$4.61K 0.12% 85
2020
Q3 		$895K Sell
14,839
-500
-3% -$30.1K 0.13% 80
2020
Q2 		$902K Hold
15,339
– – 0.15% 79
2020
Q1 		$855K Sell
15,339
-680
-4% -$41.6K 0.17% 74
2019
Q4 		$1.03M Sell
16,019
-4
-0% -$229 0.15% 80
2019
Q3 		$813K Hold
16,023
– – 0.13% 87
2019
Q2 		$727K Hold
16,023
– – 0.11% 95
2019
Q1 		$764K Hold
16,023
– – 0.11% 86
2018
Q4 		$833K Hold
16,023
– – 0.14% 81
2018
Q3 		$995K Hold
16,023
– – 0.14% 80
2018
Q2 		$887K Sell
16,023
-110
-0.7% -$5.94K 0.13% 82
2018
Q1 		$1.02M Sell
16,133
-200
-1% -$12.9K 0.15% 77
2017
Q4 		$1M Sell
16,333
-890
-5% -$55.7K 0.14% 78
2017
Q3 		$1.1M Buy
17,223
+110
+0.6% +$6.42K 0.16% 72
2017
Q2 		$954K Sell
17,113
-46
-0.3% -$2.5K 0.15% 77
2017
Q1 		$933K Hold
17,159
– – 0.14% 80
2016
Q4 		$1.28M Hold
17,159
– – 0.21% 74
2016
Q3 		$1.28M Hold
17,159
– – 0.21% 74
2016
Q2 		$1.26M Hold
17,159
– – 0.22% 72
2016
Q1 		$1.1M Buy
17,159
+50
+0.3% +$3.15K 0.2% 73
2015
Q4 		$1.18M Hold
17,109
– – 0.21% 72
2015
Q3 		$1.01M Sell
17,109
-583
-3% -$37K 0.21% 80
2015
Q2 		$1.18M Hold
17,692
– – 0.22% 74
2015
Q1 		$1.14M Hold
17,692
– – 0.2% 75
2014
Q4 		$1.04M Sell
17,692
-100
-0.6% -$5.64K 0.18% 78
2014
Q3 		$911K Sell
17,792
-300
-2% -$15K 0.16% 79
2014
Q2 		$878K Buy
18,092
+1,400
+8% +$69K 0.16% 84
2014
Q1 		$867K Sell
16,692
-400
-2% -$21.3K 0.18% 84
2013
Q4 		$908K Hold
17,092
– – 0.16% 83
2013
Q3 		$791K Buy
17,092
+100
+0.6% +$4.39K 0.15% 84
2013
Q2 		$759K Buy
+16,992
New +$738K 0.16% 81

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management's BMY Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 4.5% in Q2 2026, selling an estimated $26.6K and leaving 9,731 shares worth $561K. The position accounts for 0.05% of the portfolio, ranked #115.

Folger Nolan Fleming Douglas Capital Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.36M in Q4 2022. 800 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Folger Nolan Fleming Douglas Capital Management held 9,731 shares of Bristol-Myers Squibb worth $561K as of Q2 2026.
  • Folger Nolan Fleming Douglas Capital Management sold 463 Bristol-Myers Squibb shares in Q2 2026, an estimated $26.6K.
  • Bristol-Myers Squibb made up 0.05% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #115 holding.
  • Folger Nolan Fleming Douglas Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Folger Nolan Fleming Douglas Capital Management's Bristol-Myers Squibb position peaked at $1.36M in Q4 2022.
  • 800 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.